C193H207Cl2N55O17 — CID 158266217
1-(4-aminobutyl)-3-(3-phenylpyrido[2,3-b]pyrazin-6-yl)urea;1-[3-(N,4-dimethylanilino)pyrido[2,3-b]pyrazin-6-yl]-3-ethylurea;3-[6-(ethylcarbamoylamino)pyrido[2,3-b]pyrazin-3-yl]-N-methylbenzamide;N-[4-[6-(ethylcarbamoylamino)pyrido[2,3-b]pyrazin-3-yl]phenyl]-2-phenylacetamide;1-ethyl-3-[3-(2-methoxy-5-methylphenyl)pyrido[2,3-b]pyrazin-6-yl]urea;1-ethyl-3-[3-(4-methylphenyl)pyrido[2,3-b]pyrazin-6-yl]urea;3-ethyl-1-(3-phenylpyrido[2,3-b]pyrazin-6-yl)-1-(2-piperidin-1-ylethyl)urea;1-(4-hydroxybutyl)-3-(3-phenylpyrido[2,3-b]pyrazin-6-yl)urea;1-(5-hydroxypentyl)-3-(3-phenylpyrido[2,3-b]pyrazin-6-yl)urea;4-[(3-phenylpyrido[2,3-b]pyrazin-6-yl)carbamoylamino]butyl acetate;dihydrochloride (PubChem CID 158266217) has the molecular formula C193H207Cl2N55O17 and a molecular weight of 3640.05 g/mol. Its IUPAC name is 1-(4-aminobutyl)-3-(3-phenylpyrido[2,3-b]pyrazin-6-yl)urea;1-[3-(N,4-dimethylanilino)pyrido[2,3-b]pyrazin-6-yl]-3-ethylurea;3-[6-(ethylcarbamoylamino)pyrido[2,3-b]pyrazin-3-yl]-N-methylbenzamide;N-[4-[6-(ethylcarbamoylamino)pyrido[2,3-b]pyrazin-3-yl]phenyl]-2-phenylacetamide;1-ethyl-3-[3-(2-methoxy-5-methylphenyl)pyrido[2,3-b]pyrazin-6-yl]urea;1-ethyl-3-[3-(4-methylphenyl)pyrido[2,3-b]pyrazin-6-yl]urea;3-ethyl-1-(3-phenylpyrido[2,3-b]pyrazin-6-yl)-1-(2-piperidin-1-ylethyl)urea;1-(4-hydroxybutyl)-3-(3-phenylpyrido[2,3-b]pyrazin-6-yl)urea;1-(5-hydroxypentyl)-3-(3-phenylpyrido[2,3-b]pyrazin-6-yl)urea;4-[(3-phenylpyrido[2,3-b]pyrazin-6-yl)carbamoylamino]butyl acetate;dihydrochloride.
| Compound Name | 1-(4-aminobutyl)-3-(3-phenylpyrido[2,3-b]pyrazin-6-yl)urea;1-[3-(N,4-dimethylanilino)pyrido[2,3-b]pyrazin-6-yl]-3-ethylurea;3-[6-(ethylcarbamoylamino)pyrido[2,3-b]pyrazin-3-yl]-N-methylbenzamide;N-[4-[6-(ethylcarbamoylamino)pyrido[2,3-b]pyrazin-3-yl]phenyl]-2-phenylacetamide;1-ethyl-3-[3-(2-methoxy-5-methylphenyl)pyrido[2,3-b]pyrazin-6-yl]urea;1-ethyl-3-[3-(4-methylphenyl)pyrido[2,3-b]pyrazin-6-yl]urea;3-ethyl-1-(3-phenylpyrido[2,3-b]pyrazin-6-yl)-1-(2-piperidin-1-ylethyl)urea;1-(4-hydroxybutyl)-3-(3-phenylpyrido[2,3-b]pyrazin-6-yl)urea;1-(5-hydroxypentyl)-3-(3-phenylpyrido[2,3-b]pyrazin-6-yl)urea;4-[(3-phenylpyrido[2,3-b]pyrazin-6-yl)carbamoylamino]butyl acetate;dihydrochloride |
|---|---|
| PubChem CID | 158266217 |
| Molecular Formula | C193H207Cl2N55O17 |
| Molecular Weight | 3640.05 g/mol |
| Exact Mass | 3636.64 |
| IUPAC Name | 1-(4-aminobutyl)-3-(3-phenylpyrido[2,3-b]pyrazin-6-yl)urea;1-[3-(N,4-dimethylanilino)pyrido[2,3-b]pyrazin-6-yl]-3-ethylurea;3-[6-(ethylcarbamoylamino)pyrido[2,3-b]pyrazin-3-yl]-N-methylbenzamide;N-[4-[6-(ethylcarbamoylamino)pyrido[2,3-b]pyrazin-3-yl]phenyl]-2-phenylacetamide;1-ethyl-3-[3-(2-methoxy-5-methylphenyl)pyrido[2,3-b]pyrazin-6-yl]urea;1-ethyl-3-[3-(4-methylphenyl)pyrido[2,3-b]pyrazin-6-yl]urea;3-ethyl-1-(3-phenylpyrido[2,3-b]pyrazin-6-yl)-1-(2-piperidin-1-ylethyl)urea;1-(4-hydroxybutyl)-3-(3-phenylpyrido[2,3-b]pyrazin-6-yl)urea;1-(5-hydroxypentyl)-3-(3-phenylpyrido[2,3-b]pyrazin-6-yl)urea;4-[(3-phenylpyrido[2,3-b]pyrazin-6-yl)carbamoylamino]butyl acetate;dihydrochloride |
| SMILES | CC(=O)OCCCCNC(=O)Nc1ccc2ncc(-c3ccccc3)nc2n1.CCNC(=O)N(CCN1CCCCC1)c1ccc2ncc(-c3ccccc3)nc2n1.CCNC(=O)Nc1ccc2ncc(-c3cc(C)ccc3OC)nc2n1.CCNC(=O)Nc1ccc2ncc(-c3ccc(C)cc3)nc2n1.CCNC(=O)Nc1ccc2ncc(-c3ccc(NC(=O)Cc4ccccc4)cc3)nc2n1.CCNC(=O)Nc1ccc2ncc(-c3cccc(C(=O)NC)c3)nc2n1.CCNC(=O)Nc1ccc2ncc(N(C)c3ccc(C)cc3)nc2n1.Cl.Cl.NCCCCNC(=O)Nc1ccc2ncc(-c3ccccc3)nc2n1.O=C(NCCCCCO)Nc1ccc2ncc(-c3ccccc3)nc2n1.O=C(NCCCCO)Nc1ccc2ncc(-c3ccccc3)nc2n1 |
| InChI | InChI=1S/C24H22N6O2.C23H28N6O.C20H21N5O3.C19H21N5O2.C18H18N6O2.2C18H20N6O.2C18H19N5O2.C17H17N5O.2ClH/c1-2-25-24(32)30-21-13-12-19-23(29-21)28-20(15-26-19)17-8-10-18(11-9-17)27-22(31)14-16-6-4-3-5-7-16;1-2-24-23(30)29(16-15-28-13-7-4-8-14-28)21-12-11-19-22(27-21)26-20(17-25-19)18-9-5-3-6-10-18;1-14(26)28-12-6-5-11-21-20(27)25-18-10-9-16-19(24-18)23-17(13-22-16)15-7-3-2-4-8-15;25-12-6-2-5-11-20-19(26)24-17-10-9-15-18(23-17)22-16(13-21-15)14-7-3-1-4-8-14;1-3-20-18(26)24-15-8-7-13-16(23-15)22-14(10-21-13)11-5-4-6-12(9-11)17(25)19-2;1-4-19-18(25)22-15-10-9-14-17(21-15)23-16(11-20-14)24(3)13-7-5-12(2)6-8-13;19-10-4-5-11-20-18(25)24-16-9-8-14-17(23-16)22-15(12-21-14)13-6-2-1-3-7-13;1-4-19-18(24)23-16-8-6-13-17(22-16)21-14(10-20-13)12-9-11(2)5-7-15(12)25-3;24-11-5-4-10-19-18(25)23-16-9-8-14-17(22-16)21-15(12-20-14)13-6-2-1-3-7-13;1-3-18-17(23)22-15-9-8-13-16(21-15)20-14(10-19-13)12-6-4-11(2)5-7-12;;/h3-13,15H,2,14H2,1H3,(H,27,31)(H2,25,28,29,30,32);3,5-6,9-12,17H,2,4,7-8,13-16H2,1H3,(H,24,30);2-4,7-10,13H,5-6,11-12H2,1H3,(H2,21,23,24,25,27);1,3-4,7-10,13,25H,2,5-6,11-12H2,(H2,20,22,23,24,26);4-10H,3H2,1-2H3,(H,19,25)(H2,20,22,23,24,26);5-11H,4H2,1-3H3,(H2,19,21,22,23,25);1-3,6-9,12H,4-5,10-11,19H2,(H2,20,22,23,24,25);5-10H,4H2,1-3H3,(H2,19,21,22,23,24);1-3,6-9,12,24H,4-5,10-11H2,(H2,19,21,22,23,25);4-10H,3H2,1-2H3,(H2,18,20,21,22,23);2*1H |
| InChIKey | IRLYENJIDHXSFT-UHFFFAOYSA-N |
| XLogP | 31.57 |
| TPSA | 955.90 Ų |
| H-Bond Donors | 24 |
| H-Bond Acceptors | 50 |
| Rotatable Bonds | 53 |
| Heavy Atoms | 267 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3640.05 |
| LogP ≤ 5 | 31.57 |
| H-Bond Donors ≤ 5 | 24 |
| H-Bond Acceptors ≤ 10 | 50 |
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|